The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Henning Kelbæk
Showing 1-20 of 30 articles
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention
Madsen J,
Kelbæk H,
Nepper-Christensen L,
Jacobsen MR,
Ahtarovski KA,
Høfsten D,
Holmvang L,
Pedersen F,
Tilsted H,
Aarøe J,
Jensen SE,
Raungaard B,
Terkelsen C,
Køber L,
Engstrøm T,
Lønborg JT
March 16, 2022 | 10.4244/EIJ-D-21-00950
Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial
Saito Y,
Kelbæk H,
Xu B,
Hussain Y,
Anderson R,
Schächinger V,
Zheng M,
Wijns W,
Baumbach A,
Lansky AJ
July 20, 2021 | 10.4244/EIJ-D-20-00344
Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions
Kelbæk H,
Yeh R,
Engstrøm T,
Neumann F,
Serruys P,
Windecker S,
Belardi J,
Qiao S,
Xu B,
Liu M,
Silber S
March 19, 2021 | 10.4244/EIJ-D-19-00866
Fractional flow reserve-guided PCI in patients with and without left ventricular hypertrophy: a DANAMI-3-PRIMULTI substudy
Sabbah M,
Nepper-Christensen L,
Lønborg J,
Helqvist S,
Køber L,
Høfsten D,
Ahtarovski KA,
Göransson C,
Kyhl K,
Schoos M,
Vejlstrup N,
Kelbæk H,
Engstrøm T
September 18, 2020 | 10.4244/EIJ-D-19-00577
Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy
Schoos M,
Nepper-Christensen L,
Ahtarovski KA,
Kyhl K,
Göransson C,
Holmvang L,
Kelbæk H,
Helqvist S,
Høfsten D,
Køber L,
Vejlstrup N,
Lønborg J,
Engstrøm T
April 3, 2020 | 10.4244/EIJ-D-19-00623
Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy
De Backer O,
Lønborg J,
Helqvist S,
Warnøe J,
Kløvgaard L,
Holmvang L,
Pedersen F,
Tilsted H,
Raungaard B,
Jørgensen E,
Køber L,
Høfsten D,
Kelbæk H,
Engstrøm T
June 20, 2019 | 10.4244/EIJ-D-18-00766
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments
Kjoller-Hansen L,
Bligaard N,
Kelbæk H,
Christiansen E,
Thuesen L,
Hansen PR,
Engstrøm T,
Junker A,
Abildgaard U,
Lassen J,
Jensen JS,
Jeppesen JL,
Galloe A
September 20, 2018 | 10.4244/EIJ-D-18-00396
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy
Nepper-Christensen L,
Lønborg J,
Hofsten D,
Ahtarovski KA,
Kyhl K,
Göransson C,
Køber L,
Helqvist S,
Pedersen F,
Kelbæk H,
Vejlstrup N,
Holmvang L,
Engstrøm T
August 24, 2018 | 10.4244/EIJ-D-17-00857
To defer, or not to defer, that is the question
Kelbæk H,
Hofsten D,
Engstrøm T
July 20, 2017 | 10.4244/EIJV13I4A58
Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy
Sadjadieh G,
Engstrøm T,
Helqvist S,
Hofsten D,
Køber L,
Pedersen F,
Clemmensen P,
Jørgensen E,
Saunamäki K,
Tilsted H,
Kelbæk H,
Holmvang L
November 20, 2016 | 10.4244/EIJV12I10A203
Acute myocardial infarction and lesion location in the left circumflex artery: importance of coronary artery dominance
Waziri H,
Jørgensen E,
Kelbæk H,
Fosbøl E,
Pedersen F,
Mogensen U,
Gerds T,
Køber L,
Wachtell K
July 20, 2016 | 10.4244/EIJY15M09_04
A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction
Kyhl K,
Lønborg J,
Vejlstrup N,
Kelbæk H,
Helqvist S,
Holmvang L,
Jørgensen E,
Saunamäki K,
Bøtker H,
Clemmensen P,
Køber L,
Treiman M,
Engstrøm T
July 20, 2016 | 10.4244/EIJV12I4A78
Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis
De Backer O,
Biasco L,
Lønborg J,
Pedersen F,
Holmvang L,
Kelbæk H,
Arnous S,
Saunamäki K,
Helqvist S,
Kastrup J,
Jørgensen E,
Engstrøm T
February 12, 2016 | 10.4244/EIJV11I11A247
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H,
Holmvang L,
Richardt G,
Eberli F,
Stella P,
Buszman P,
Neumann F,
Serruys P,
Windecker S,
Widimský P,
Belardi J,
Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction
Schoos M,
Pedersen F,
Holmvang L,
Engstrøm T,
Saunamäki K,
Helqvist S,
Kastrup J,
Mehran R,
Dangas G,
Jørgensen E,
Kelbæk H,
Clemmensen P
September 22, 2015 | 10.4244/EIJY14M11_07
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabaté M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?
Martin-Yuste V,
Alvarez-Contreras L,
Sabaté M,
Kelbæk H,
Saunamäki K,
Jørgensen E,
Kocka V
February 20, 2015 | 10.4244/EIJV10I10A208
ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction
Lønborg J,
Kelbæk H,
Engstrøm T,
Helqvist S,
Kløvgaard L,
Holmvang L,
Vejlstrup N,
Jørgensen E,
Saunamäki K,
Dridi N,
Kaltoft A,
Bøtker H,
Clemmensen P,
Terkelsen C
August 19, 2014 | 10.4244/EIJV10I4A80
Flow disturbances in stent-related coronary evaginations: a computational fluid-dynamic simulation study
Radu M,
Pfenniger A,
Räber L,
de Marchi S,
Obrist D,
Kelbæk H,
Windecker S,
Serruys P,
Vogel R
May 20, 2014 | 10.4244/EIJV10I1A18
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation
Radu M,
Räber L,
Heo J,
Gogas B,
Jørgensen E,
Kelbæk H,
Muramatsu T,
Farooq V,
Helqvist S,
Garcia-Garcia H,
Windecker S,
Saunamäki K,
Serruys P
January 20, 2014 | 10.4244/EIJV9I9A183
1
2
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke